Drugs & TargetsFree Innova Therapeutics receives Rare Pediatric Disease Designation from FDA for IVT-8086 for Osteosarcoma October 02, 2020Vol.46 No.37
Drugs & TargetsFree Celyad Oncology collaborates with MSD to evaluate CYAD-101 with Keytruda in microsatellite stable mCRC October 02, 2020Vol.46 No.37
Drugs & TargetsFree University of Illinois scientists enter licensing deal with Bayer, Systems Oncology October 02, 2020Vol.46 No.37
Drugs & TargetsFree Elevation Oncology and US Oncology Research collaborate to expand genomic testing of solid tumors October 02, 2020Vol.46 No.37
Drugs & Targets Expanded access eRequest app allows physicians to submit EA requests online September 25, 2020Vol.46 No.36
Drugs & Targets FDA accepts for priority review application for anti-BCMA CAR T-cell therapy idecabtagene vicleucel (Ide-cel, bb2121) September 25, 2020Vol.46 No.36
Drugs & Targets Agenus begins rolling BLA submission of balstilimab to FDA for treatment of recurrent/metastatic cervical cancer September 25, 2020Vol.46 No.36
Drugs & Targets FDA accepts sNDA for Xalkori for pediatric ALK-positive anaplastic large cell lymphoma September 25, 2020Vol.46 No.36
Drugs & Targets EMA’s CHMP issues positive opinion for Zejula in ovarian cancer indication September 25, 2020Vol.46 No.36
Drugs & TargetsFree Rhenium NanoLiposomes receives Fast Track Designation from FDA for glioblastoma treatment September 18, 2020Vol.46 No.35
